Pulmonary prophylactic impact of melatonin and/or quercetin: A novel therapy for inflammatory hypoxic stress in rats Cover

.blurhash-client-img { display: none !important; }

Pulmonary prophylactic impact of melatonin and/or quercetin: A novel therapy for inflammatory hypoxic stress in rats

Acta Pharmaceutica

Volume 67 (2017): Issue 1 (March 2017)

By: Nouf M. Al-Rasheed, Laila Fadda, Hala A. Attia, Iman A. Sharaf, Azza M. Mohamed and Nawal M. Al-Rasheed

Open Access

|Feb 2017

Authors

Nouf M. Al-Rasheed

Department of Pharmacology King Saud University, Riyadh, Saudi Arabia

Laila Fadda

Department of Pharmacology King Saud University, Riyadh, Saudi Arabia

Hala A. Attia

Department of Pharmacology King Saud University, Riyadh, Saudi Arabia

Iman A. Sharaf

Biochemistry Department Faculty of Science, Al Faisaliah King Abdulaziz University, Jeddah, Saudi Arabia

Biochemistry Department Medical Research Institute Alexandria University, Egypt

Azza M. Mohamed

azzamohamed99@yahoo.com

Biochemistry Department Faculty of Science, Al Faisaliah King Abdulaziz University, Jeddah, Saudi Arabia

Therapeutic Chemistry Department National Research Center, Dokki, Egypt

Nawal M. Al-Rasheed

Department of Pharmacology King Saud University, Riyadh, Saudi Arabia

DOI: https://doi.org/10.1515/acph-2017-0010 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 125 - 135

Accepted on: Dec 14, 2016

Published on: Feb 21, 2017

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

inflammatory mediators,

heat shock protein

Related subjects:

Pharmacy, other

© 2017 Nouf M. Al-Rasheed, Laila Fadda, Hala A. Attia, Iman A. Sharaf, Azza M. Mohamed, Nawal M. Al-Rasheed, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 67 (2017): Issue 1 (March 2017)Next article